Carbylan Therapeutics
Delivering premier therapies to fast-growing markets with significant clinical needs
Delivering premier therapies to fast-growing markets with significant clinical needs
Carbylan Therapeutics is a clinical-stage specialty pharmaceutical company founded in 2005 with a mission to deliver premier therapies to expanding markets in Health Care and Health and Wellness sectors. Based in Palo Alto, California, the company focuses on developing and commercializing unique combination therapies. Their slogan, "Delivering premier therapies to fast-growing markets with significant clinical needs," underscores their commitment to addressing unmet clinical needs. In March 2015, Carbylan Therapeutics secured a $4.00M Debt Financing investment, signaling investor confidence in their innovative approach.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $4.00M | - | 06 Mar 2015 | |
| Debt Financing | $5.00M | - | 14 Oct 2014 | |
| Venture Round | $6.00M | 3 |
|
03 Jan 2013 |
| Series B | $20.00M | 3 |
|
26 Nov 2007 |
| Series A | $7.75M | 2 |
|
06 Jan 2006 |
No recent news or press coverage available for Carbylan Therapeutics.
-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
